DJ Amgen Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slid 1.45% to $350.16 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.24% to 7,109.14 and Dow Jones Industrial Average falling 0.01% to 49,442.56.
The stock's fall snapped a two-day winning streak.
Amgen Inc. closed 10.51% short of its 52-week high of $391.29, which the company achieved on March 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.49% to $230.69, Pfizer Inc. $(PFE)$ fell 0.15% to $27.52, and AbbVie Inc. $(ABBV)$ fell 2.24% to $203.71.
Trading volume (2.0 M) remained 662,531 below its 50-day average volume of 2.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 20, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments